Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer Registry

1. Bjartell, A.
2. Lumen, N.
3. Maroto, P.
4. Paiss, T.
5. Gomez-Veiga, F.
6. Birtle, A.
7. Kramer, G.
8. Kalinka, E.
9. Spaëth, D.
10. Feyerabend, S.
11. Matveev, V.
12. Lefresne, F.
13. Lukac, M.
14. Wapenaar, R.
15. Costa, L.
16. Chowdhury, S.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1007/S11523-021-00807-4 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus